Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.
Press releases published on September 8, 2025
Tender Care PPEC Honored with Multiple Wins in 2025 Best of Florida Awards
EIN Presswire
·
September 8, 2025
Tender Care PPEC earns top honors in pediatric care with 3 wins in the 2025 Best of Florida Awards. FT. LAUDERDALE, FL, UNITED STATES, September 8, 2025 /EINPresswire.com/ -- Tender Care PPEC is proud to announce its recognition as a top healthcare …
iRemedy Officially Launches Nationwide Incubator Solution With UPS Healthcare
EIN Presswire
·
September 8, 2025
STUART, FL, UNITED STATES, September 8, 2025 /EINPresswire.com/ -- The iRemedy Healthcare Companies, Inc. (“iRemedy”), a healthcare supply chain technology company, today announced the official start of its Incubator Solution, a first-of-its-kind program …
Velocity Revenue Partners Launches AI-Powered Marketing Services for Healthcare and Insurance Industries in Florida
EIN Presswire
·
September 8, 2025
TAMPA, FL, UNITED STATES, September 8, 2025 /EINPresswire.com/ -- Velocity Revenue Partners today announced the official launch of its operations in Florida, offering specialized marketing and AI-driven growth solutions designed specifically for …
Brightpoint AI to Showcase Next-Gen AI Solutions at Community Summit NA 2025 in Orlando, Florida
EIN Presswire
·
September 8, 2025
Brightpoint AI is thrilled to announce its participation at Community Summit NA 2025, the largest independent Microsoft Business Applications user conference CORAL SPRINGS, FL, UNITED STATES, September 8, 2025 /EINPresswire.com/ -- This year, …
Harrow Announces Pricing of $250.0 Million Offering of Senior Unsecured Notes Due 2030
GlobeNewswire
·
September 8, 2025
NASHVILLE, Tenn., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced the pricing of its private offering (the “Offering”) of $250.0 million aggregate …
NurExone Receives U.S. Patent Allowance for Exosome Manufacturing, Strengthening Supply Chain Readiness
GlobeNewswire
·
September 8, 2025
TORONTO and HAIFA, Israel, Sept. 08, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”), a pioneering biopharmaceutical company developing exosome-based regenerative therapies, is pleased to …
Onco360® Has Been Selected as a National Specialty Pharmacy Partner for Wayrilz™ (rilzabrutinib)
GlobeNewswire
·
September 8, 2025
LOUISVILLE, Ky., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent specialty pharmacy, has been selected as a pharmacy partner by Sanofi for Wayrilz (rilzabrutinib), which has been approved by the U.S. Food and Drug …
Sienna Senior Living Announces the Opening of Its Long-Term Care Community in North Bay and Retirement Community in Brantford, Ontario
GlobeNewswire
·
September 8, 2025
MARKHAM, Ontario, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. ("Sienna" or the "Company") (TSX: SIA) announced today that it has officially opened its Northern Heights Community, the Company’s first completed long-term care redevelopment …
PharmAla Completes Import of LaNeo MDMA for US Distribution
GlobeNewswire
·
September 8, 2025
TORONTO, Sept. 08, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of novel MDXX class molecules (including its …
Immix Biopharma Announces Strategic Investment by Houston based Goose Capital, led by founding member Dr. Nancy T. Chang
GlobeNewswire
·
September 8, 2025
LOS ANGELES, CA, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“Immix”, “Company”, “We” or “Us” or ”IMMX”), a clinical-stage biopharmaceutical company developing cell therapies for AL Amyloidosis and other serious diseases, today announced that …
Ultragenyx Announces Positive Longer-term Data from Phase 3 Study of DTX401 AAV Gene Therapy for the Treatment of Glycogen Storage Disease Type Ia (GSDIa)
GlobeNewswire
·
September 8, 2025
At Week 96 participants experienced even greater reductions in daily cornstarch intake while maintaining low levels of hypoglycemia, improved levels of euglycemia and improved fasting tolerance Phase 3 results are further supported by early data from open- …
Enovis Corporation Announces Time Change for Presentation at Baird 2025 Global Healthcare Conference
GlobeNewswire
·
September 8, 2025
Wilmington, DE, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that it will now present at the Baird 2025 Global Healthcare Conference at 2:35 p.m. ET on …
Rapport Announces Proposed Public Offering of Common Stock
GlobeNewswire
·
September 8, 2025
BOSTON and SAN DIEGO, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the discovery and development of small molecule precision medicines for …
NeuroOne® to Participate in Sidoti Small-Cap Conference on September 17th and 18th, 2025
GlobeNewswire
·
September 8, 2025
EDEN PRAIRIE, Minn., Sept. 08, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from …
Dianthus Therapeutics, Inc. Announces Proposed $150 Million Underwritten Public Offering
GlobeNewswire
·
September 8, 2025
NEW YORK and WALTHAM, Mass., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement therapeutics to treat severe autoimmune …
Abivax Presents First Half 2025 Financial Results
GlobeNewswire
·
September 8, 2025
Abivax Presents First Half 2025 Financial Results PARIS, France, September 8, 2025, 10:00 p.m. CEST – Abivax SA (Euronext Paris: FR0012333284 – ABVX / Nasdaq – ABVX) (“Abivax” or the “Company”), a clinical-stage biotechnology company focused on developing …
Nora Mental Health Opens New Location in Dallas, TX, Bringing Compassionate, Accessible Mental Health Care to the Community
GlobeNewswire
·
September 8, 2025
Dallas, TX , Sept. 08, 2025 (GLOBE NEWSWIRE) -- Nora Mental Health is excited to announce the grand opening of its newest clinic in Dallas, Texas, located at 8140 Walnut Hill Ln, Suite 835. The new location reflects the growing demand for accessible, high- …
Claisen Launches Direct-to-Consumer Personalized Kits for Gastrointestinal Diseases (Heartburn, Bloating, and Gas)
GlobeNewswire
·
September 8, 2025
BOSTON, MA, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Claisen Inc., a telemedicine and digital gastrointestinal health company, today announced the launch of personalised, direct-to-consumer gut health kits that help patients manage acid reflux/GERD, bloating, …
Beyond Air Announces Exercise of Warrants for $3.25 Million of Gross Proceeds
GlobeNewswire
·
September 8, 2025
GARDEN CITY, N.Y., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve the lives …
Graphy Inc. Showcases continued Shape Memory Aligner interest in the North American market at EAS North America Forum
EIN Presswire
·
September 8, 2025
Graphy spotlights SMA innovation and global expansion at EAS North America Forum, marking its strategic debut in the U.S. aligner market. MIAMI, FL, UNITED STATES, September 8, 2025 /EINPresswire.com/ -- Graphy Inc., the world’s first company to …